Quote Level 2 Charts News Trades Historical Financials Message Board
Albany Molecular Research, Inc. (MM)
   

Albany Molecular Research Inc

Visual Financials
Company Name: Albany Molecular Research Inc
Ticker Symbol: AMRI
CIK Number: 0001065087
WWW Address: http://www.amriglobal.com
CEO: William S. Marth
No. of Employees: 2,220
Common Issue Type: CS
Business Description:Albany Molecular Research, Inc., is a contract research and manufacturing organization providing customers drug discovery, development and manufacturing services.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 14.32 Down -0.16 14.32 16.0 14.43 14.50 14.17 307897
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 511.3 35.7 0.00 -0.07 0.00 0.0 0.0 22.48 - 12.45
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close14.34$
PE Ratio - LTM0.0
Market Capitalisation511.3mil
Latest Shares Outstanding35.7mil
Earnings pS (EPS)-0.07$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee181,241$
Effective Tax Rate0.0%
Float26.3mil
Float as % of Shares Outstanding0.7%
Foreign Sales145mil
Domestic Sales258mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.20%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin26.6%
EBITDA Margin10.7%
Pre-Tax Profit Margin-0.9%
Assets Turnover58.1%
Return on Assets (ROA)-0.3%
Return on Equity (ROE)-0.9%
Return on Capital Invested (ROCI)2.0%
Current Ratio2.8
Leverage Ratio (Assets/Equity)3.0
Interest Cover0.8
Total Debt/Equity (Gearing Ratio)1.36
LT Debt/Total Capital57.0%
Working Capital pS5.07$
Cash pS0.00$
Book-Value pS8.04$
Tangible Book-Value pS-0.07$
Cash Flow pS1.40$
Free Cash Flow pS0.51$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.78
Price/Tangible Book Ratio0.00
Price/Cash Flow10.3
Price/Free Cash Flow27.9
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.1228,1991,313,947
4 Weeks14.9513.1113.457.74195,8063,916,138
13 Weeks15.7312.4515.42-6.1-11259,91316,634,444
26 Weeks16.8012.4515.58-7.1-22258,39832,816,581
52 Weeks22.4812.4521.07-31.3-34283,32171,680,261
YTD19.6512.45--24.0-32264,65038,109,694
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
14.1314.2614.1215.0216.190.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.150.50.21
Income0.0
Dividend0.0
Capital SpendingNA0.37
R&D-34.91NA-57.95
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %9.244.39.2
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.960.890.96
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio20.93
Current Ratio2.8
Quick Ratio (Acid Test)1.7
Liquidity Ratio (Cash)1.03
Receivables Turnover4.4
Average Collection Period82
Working Capital/Equity63.1
Working Capital pS5.06
Cash-Flow pS1.19
Free Cash-Flow pS0.53
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.34
Financial Leverage Ratio (Assets/Equity)1.4
Debt Ratio45.0
Total Debt/Equity (Gearing Ratio)1.36
LT Debt/Equity1.30
LT Debt/Capital Invested70.8
LT Debt/Total Liabilities96.0
Interest Cover0.8
Interest/Capital Invested2.52
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.59
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA23.02
Enterprise Value (EV)/Free Cash Flow46.52
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM1.78
Price/Cash Flow Ratio10.3
Price/Free Cash Flow Ratio - LTM27.9
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-79.4
5-Y Low P/E Ratio-6.9
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM40.6
PER SHARE FIGURES
LT Debt pS14.58
Current Liabilities pS3.87
Tangible Book Value pS - LTM-0.07
Book Value pS - LTM8.04
Capital Invested pS18.95
Cash pS - LTM0.00
Cash Flow pS - LTM1.40
Free Cash Flow pS - LTM0.51
Earnings pS (EPS)-0.07
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin4.34
Free Cash Flow Margin 5YEAR AVG0.29
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity1.40
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.59
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.60
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin26.6
Gross Profit Margin - 5YEAR AVRG.0.3
EBITDA Margin - LTM10.7
EBIT Margin - LTM3.9
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate-85.2
Effective Tax Rate - 5YEAR AVRG.645.4
EFFICIENCY RATIOS
Cash Conversion Cycle1,477,656
Revenue per Employee181,241
Net Income per Employee
Average Collection Period1,477,656
Receivables Turnover4.4
Day's Inventory Turnover Ratio
Inventory Turnover4.2
Inventory/Sales22.2
Accounts Payble/Sales0.00
Assets/Revenue1.67
Net Working Capital Turnover2.22
Fixed Assets Turnover0.69
Total Assets Turnover0.6
Revenue per $ Cash8.15
Revenue per $ Plant1.92
Revenue per $ Common Equity1.40
Revenue per $ Capital Invested0.59
Selling, General & Adm/tive (SG&A) as % of Revenue19.4
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue1.4
R&D Expense as % of Revenue - 5YEAR AVRG.1.4

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.